Showing results (91-100 of 217) with videos related to

Sort By:
Pageof 22
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: neuroblastomaJulie R Park, Rochelle Bagatell, Wendy B London, et al.
Pediatric Blood & Cancer|January 4, 2012
Locoregional MYCN-amplified neuroblastomaAndres Morales La Madrid, Samuel Volchenboum, Julie M Gastier-Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Prominent microvascular proliferation in clinically aggressive neuroblastomaRadhika Peddinti, Rana Zeine, Dragos Luca, et al.
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
Pediatric Blood & Cancer|July 24, 2008
Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) projectSteven G Dubois, Wendy B London, Yang Zhang, et al.
British Journal of Cancer|October 13, 2022
Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International ConsortiumAdriana Fonseca, João Lobo, Florette K Hazard, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastomaOmar R Vayani, Maria E Kaufman, Kelley Moore, et al.
Pediatric Blood & Cancer|December 8, 2011
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growthNisha C Kakodkar, Radhika R Peddinti, Yufeng Tian, et al.
Pediatric Blood & Cancer|September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitroHolly J Meany, Dan L Sackett, John M Maris, et al.
Pediatric Blood & Cancer|October 20, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastomaOmar R Vayani, Maria E Kaufman, Kelley Moore, et al.
Pageof 22